Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Pradeep Kumar Sacitharan was recently awarded a European Institute of Innovation and Technology Health (EIT Health) PhD transition fellowship. This fellowship programme is designed to address the funding gap students often face between completing their doctoral work and obtaining further funding to develop innovative ideas arising from their studies.

Under the supervision of Dr James Edwards and Prof Tonia Vincent, Pradeep's doctoral work examined the biological processes that increase risk of osteoarthritis during ageing. The transition fellowship will support Pradeep as he explores whether processes affected by ageing can be targeted with drugs to treat osteoarthritis.

Speaking of his award, Pradeep said: 'I am grateful to receive this timely fellowship and hope to build on it. These opportunities really do support final year PhD students during the tricky and difficult interim period between finishing their studies and securing their first funding. I have received this wonderful opportunity and hope other PhD students in the future have the same chance.

The fellowship will support Pradeep as he applies for long-term fellowships and grants.

Similar stories

Novo Nordisk Postdoctoral Research Fellowship awarded to Inhye Park

Inhye Park has been awarded a Novo Nordisk Postdoctoral Research Fellowship to research the biology of resident vascular macrophages in atherosclerosis.

Researchers from the Kennedy Institute awarded MRC funding

Tonia Vincent, Jelena Bezbradica and Alex Clarke have been awarded funding grants by the Medical Research Council (MRC) for different projects.

EPSRC funds research to avert an antibiotics apocalypse

Researchers at the Kennedy Institute join a collaboration to find new ‘drug-free’ ways of treating illnesses where current treatments have become ineffective due to antibiotic resistance.

Major ERC funding awarded to Professor Michael Dustin

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.

Oxford University awarded £2.4 million to fund DPhil research in inflammation, immunology and musculoskeletal disease

Oxford University has today been awarded a £2.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.